Tratamiento con caspofungina de endocarditis por Candida tropicalis resistente a fluconazol / Treatment with caspofungin of Candida tropicalis endocarditis resistant to fluconazol
Medicina (B.Aires)
; 64(2): 152-154, 2004.
Article
in Es
| LILACS
| ID: lil-444338
Responsible library:
BR1.1
ABSTRACT
Fungal endocarditis, in particular due to Candida species, requires medical and surgical treatment and amphotericin B is the drug of choice. Caspofungin is an echinocandin very effective against Candida and Aspergillus. We present a patient with Candida tropicalis endocarditis, fluconazol resistant, treated with caspofungin, on a compassional basis as a result of adverse effects with amphotericin B. The patient had a microbiological response.
RESUMEN
Las endocarditis causadas por hongos, (Candida en particular), requieren tratamiento médico-quirúrgico,siendo la anfotericina B la droga de elección. Caspofungina es una equinocandina con gran actividadsobre Candida y Aspergillus. Se presenta un paciente con una endocarditis por Candida tropicalis resistente a fluconazol tratado con caspofungina bajo un esquema de salvataje, luego de haber presentado efectos adversos por anfotericina B. El paciente tuvo respuesta microbiológica.
Full text:
1
Index:
LILACS
Main subject:
Peptides, Cyclic
/
Candidiasis
/
Fluconazole
/
Candida tropicalis
/
Endocarditis
/
Antifungal Agents
Limits:
Aged
/
Humans
/
Male
Language:
Es
Journal:
Medicina (B.Aires)
Journal subject:
MEDICINA
Year:
2004
Type:
Article